Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Aluminium adjuvants, typically referred to as 'alum', are the most commonly used adjuvants in human and animal vaccines worldwide, yet the mechanism underlying the stimulation of the immune system by alum remains unknown. Toll-like receptors are critical in sensing infections and are therefore common targets of various adjuvants used in immunological studies. Although alum is known to induce the production of proinflammatory cytokines in vitro, it has been repeatedly demonstrated that alum does not require intact Toll-like receptor signalling to activate the immune system. Here we show that aluminium adjuvants activate an intracellular innate immune response system called the Nalp3 (also known as cryopyrin, CIAS1 or NLRP3) inflammasome. Production of the pro-inflammatory cytokines interleukin-1beta and interleukin-18 by macrophages in response to alum in vitro required intact inflammasome signalling. Furthermore, in vivo, mice deficient in Nalp3, ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain) or caspase-1 failed to mount a significant antibody response to an antigen administered with aluminium adjuvants, whereas the response to complete Freund's adjuvant remained intact. We identify the Nalp3 inflammasome as a crucial element in the adjuvant effect of aluminium adjuvants; in addition, we show that the innate inflammasome pathway can direct a humoral adaptive immune response. This is likely to affect how we design effective, but safe, adjuvants in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Cited by
Items 801–900 of 1,002
Lin, L., Ibrahim, A. S., Baquir, B., Avanesian, V., Fu, Y., & Spellberg, B. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00531.x · Cited by 29
“Furthermore, a recent study reported that a major mechanism by which aluminum adjuvants enhance immune responses was by direct agonism of an intracellular pattern recognition receptor, Nalp3 (Eisenbarth et al ., 2008).”
BackgroundInfluentialRiner, D. K., Ferragine, C. E., Maynard, S. K., & Davies, S. J. A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003708 · Cited by 33
“In further support of a role for inflammasome-mediated inflammation in stimulating parasite development, we also found that treatment with alum, an exogenous NALP3 inflammasome agonist [24,25], also resulted in robust restoration of parasite growth (Figure 2E) and partial restoration of egg production (Figure 2F) in R…”
BackgroundKhameneh, H. J., Ho, A. W. S., Spreafico, R., Derks, H., Quek, H. Q. Y., & Mortellaro, A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600420 · Cited by 31
“Interestingly, IL-2–mediated alum responses in vivo occurred in the absence of an experimentally applied priming stimulus, such as LPS, reminiscent of particulatedriven NLRP3 activation that requires priming in vitro but not in vivo (22, 34, 35).”
InfluentialSialoside-based pattern recognitions discriminating infections from tissue injuries
Liu, Y., Chen, G.-Y., & Zheng, P. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.10.004 · Cited by 28
“Data reported by three independent groups [21 ,22,23] showed a critical role for NLRP3 in adjuvant activity of alum.”
ResultBasic Properties and Development Status of Aluminum Adjuvants Used for Vaccines
Lan, J., Feng, D., He, X., Zhang, Q., & Zhang, R. (2024) · Vaccines · doi:10.3390/vaccines12101187 · Cited by 38
“For instance, Eisen-barth [42] and Li [43] found that the NLRP3 inflammasome induced by aluminum adjuvant is necessary for its immunomodulatory activity.”
BackgroundWu, C.-Y., Hua, K., Yang, S., Tsai, Y., Yang, S., Hsieh, C., Wu, C., Chang, J., Arbiser, J. L., Chang, C., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15663 · Cited by 29
Mucosal Adjuvants for Influenza Virus-Like Particle Vaccine
Quan, F., Ko, E., Kwon, Y., Joo, K. H., Compans, R. W., & Kang, S. (2013) · Viral Immunology · doi:10.1089/vim.2013.0013 · Cited by 28
“Alternatively, alum can act as an adjuvant in the presence or absence of NALP3 and IL-1 b (5,16,38).”
MacSharry, J. A., Shalaby, K. H., Marchica, C. L., Farahnak, S., Chieh-Li, T., Lapthorne, S., Qureshi, S. T., Shanahan, F., & Martin, J. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098648 · Cited by 28
“[29] However, the administration of exogenous LPS to OVA challenged C57Bl/6 mice is inhibitory of eosinophilia [20] as is high dose LPS challenge of BALB/c mice [25], indicating that the timing, route of administration, origin and dose of LPS may have important influences on the outcome of the challenge.”
BackgroundAn update on the use of laser technology in skin vaccination
Chen, X., Wang, J., Shah, D., & Wu, M. X. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.844070 · Cited by 29
Chen, K. W., Bezbradica, J. S., Groß, C. J., Wall, A. A., Sweet, M. J., Stow, J. L., & Schroder, K. (2016) · European Journal of Immunology · doi:10.1002/eji.201545943 · Cited by 32
Liver X receptors agonists suppress NLRP3 inflammasome activation
Yu, S.-X., Chen, W., Hu, X.-Z., Feng, S., Li, K.-Y., Qi, S., Lei, Q.-Q., Hu, G., Li, N., Zhou, F., et al. (2016) · Cytokine · doi:10.1016/j.cyto.2016.12.003 · Cited by 31
Commensal bacteria aggravate allergic asthma via NLRP3/IL-1β signaling in post-weaning mice
Huang, C., Wang, J., Zheng, X., Chen, Y., Zhou, R., Wei, H., Sun, R., & Tian, Z. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.07.003 · Cited by 30
Batista-Duharte, A., Lastre, M., & Pérez, O. (2013) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2012.11.012 · Cited by 31
The Dual Role of the Airway Epithelium in Asthma: Active Barrier and Regulator of Inflammation
Frey, A., Lunding, L. P., & Wegmann, M. (2023) · Cells · doi:10.3390/cells12182208 · Cited by 31
Cutting Edge: Nitrogen Bisphosphonate-Induced Inflammation Is Dependent upon Mast Cells and IL-1
Norton, J. T., Hayashi, T., Crain, B., Cho, J. S., Miller, L. S., Corr, M., & Carson, D. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100830 · Cited by 28
“Casp12/2 and Myd882/2 mice were gifts from Dr. R. Flavell (Yale University, New Haven, CT) (10) and Dr. S. Akira (Osaka University, Osaka, Japan) (11), respectively, and were maintained on a C57BL/ 6 background at University of California San Diego.”
Plasticizer DBP Activates NLRP3 Inflammasome through the P2X7 Receptor in HepG2 and L02 Cells
Ni, J., Zhang, Z., Luo, X., Xiao, L., & Wang, N. (2015) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21776 · Cited by 29
Müller, M., & Buchner, M. R. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201903439 · Cited by 27
Wang, M.-X., Chen, J., Zhang, R., Guo, X., Chen, D., Guo, X., Chen, Y., Wu, Y., Sun, J., Liu, Y., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105321 · Cited by 28
Puth, S., Verma, V., Hong, S. H., Tan, W., Lee, S. E., & Rhee, J. H. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121542 · Cited by 29
The role of innate immunity in the pathogenesis of asthma
Schröder, N. W. J. (2008) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32831d0f99 · Cited by 31
Jully, V., Mathot, F., Moniotte, N., Véronique Préat, A., & Lemoine, D. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.03.032 · Cited by 27
Mitochondrial ROS activate interleukin‑1β expression in allergic rhinitis
Shi, Q., Lei, Z., Cheng, G., Li, D., Wang, Q., Luo, S., Yang, H., & Jia, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8984 · Cited by 36
“Previous studies have reported on the pathological roles of IL-1 β and the NLRP3 inflammasome in the development of allergic asthma, though the results were conflicting (19-23).”
Adjuvanted leptospiral vaccines: Challenges and future development of new leptospirosis vaccines
Teixeira, A. F., Fernandes, L. G. V., Cavenague, M. F., Takahashi, M., Santos, J. C., Passalia, F. J., Daroz, B. B., Kochi, L. T., Vieira, M. L., & Nascimento, A. L. T. O. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.05.087 · Cited by 35
Moving from Empirical to Rational Vaccine Design in the ‘Omics’ Era
Sharma, M., Krammer, F., García‐Sastre, A., & Tripathi, S. (2019) · Vaccines · doi:10.3390/vaccines7030089 · Cited by 29
“For example, for the most commonly used adjuvant, alum, the molecular events leading to enhanced immune response are still not clear, although the NALP3 inflammasome has been implicated [33].”
BackgroundImmune Complexes Inhibit IL-1 Secretion and Inflammasome Activation
Janczy, J. R., Çıracı, C., Haasken, S., Iwakura, Y., Olivier, A. K., Cassel, S. L., & Sutterwala, F. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400628 · Cited by 31
“Previous studies have shown a requirement for the NLRP3 inflammasome in the development of alum-Ag–dependent Th2 responses (27, 28).”
BackgroundSelf-citationWang, X., Yao, X., Wan, Y., Wang, B., Xu, J., & Wen, Y. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.11.005 · Cited by 26
Mesoporous Caged‐γ‐AlOOH‐Double‐Stranded RNA Analog Complexes for Cancer Immunotherapy
Li, X., Shenashen, M. A., Wang, X., Ito, A., Taniguchi, A., & El‐Safty, S. A. (2017) · Advanced Biosystems · doi:10.1002/adbi.201700114 · Cited by 26
Longevity of vaccine protection: Immunological mechanism, assessment methods, and improving strategy
Chen, Z., Gao, X., & Yu, D. (2022) · View · doi:10.1002/viw.20200103 · Cited by 34
Emulsions as Vaccine Adjuvants
Shah, R. R., Brito, L. A., O’Hagan, D. T., & Amiji, M. M. (2014) · Advances in delivery science and technology · doi:10.1007/978-1-4939-1417-3_4 · Cited by 26
Wüthrich, M., LeBert, V., Galles, K., Hu‐Li, J., Ben-Sasson, S. Z., Paul, W. E., & Klein, B. S. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit283 · Cited by 28
“because it also induces IL-1 [13, 29].”
Shomali, M., Freitag, A., Engert, J., Siedler, M., Kaymakcalan, Z., Winter, G., Carpenter, J. F., & Randolph, T. W. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23772 · Cited by 28
Al adjuvants can be tracked in viable cells by lumogallion staining
Mile, I., Svensson, A., Darabi, A., Mold, M. J., Siesjö, P., & Eriksson, H. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.04.008 · Cited by 33
Csillag, A., Kumar, B. V., Szabó, K., Szilasi, M., Papp, Z., Szilasi, M. E., Pázmándi, K., Boldogh, I. R., Rajnavölgyi, É., Bácsi, A., et al. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0097 · Cited by 26
A clinically applicable adjuvant for an atherosclerosis vaccine in mice
Kobiyama, K., Vassallo, M., Mitzi, J., Winkels, H., Pei, H., Kimura, T., Miller, J. F., Wolf, D., & Ley, K. F. (2018) · European Journal of Immunology · doi:10.1002/eji.201847584 · Cited by 28
Lu, F., Mosley, Y. C., Carmichael, B. E., Brown, D. D., & HogenEsch, H. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.02.033 · Cited by 29
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®)
Heath, M. D., Mohsen, M. O., de Kam, P., Velazquez, T. L. C., Hewings, S. J., Kramer, M. F., Kündig, T. M., Bachmann, M. F., & Skinner, M. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594911 · Cited by 27
Huang, H., Qiao, Y., Chu, L., Ye, C., Lin, L., Liao, H., Meng, X., Zou, F., Zhao, H., Zou, M., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111917 · Cited by 28
Re-inventing traditional aluminum-based adjuvants: Insight into a century of advancements
Gogoi, H., Mani, R., & Bhatnagar, R. (2024) · International Reviews of Immunology · doi:10.1080/08830185.2024.2404095 · Cited by 26
“…et al., and Eisenbarth et al., demonstrated that alum adjuvanted with model antigens like DT/OVA/HSA failed to induce antigen specific antibody and Th2 T cells priming in NLRP3, ASC-, or caspase 1-deficient mice thereby establishing the role of NLRP3 mediated mechanism of adjuvant activity [81,82].”
Bassi, N., Luisetto, R., Prete, D. D., Ghirardello, A., Ceol, M., Rizzo, S., Iaccarino, L., Gatto, M., Valente, M., Punzi, L., et al. (2012) · Lupus · doi:10.1177/0961203311429553 · Cited by 25
Arf6 exacerbates allergic asthma through cell-to-cell transmission of ASC inflammasomes
Lee, S., Ishitsuka, A., Kuroki, T., Lin, Y.-H., Shibuya, A., Hongu, T., Funakoshi, Y., Kanaho, Y., Nagata, K., & Kawaguchi, A. (2021) · JCI Insight · doi:10.1172/jci.insight.139190 · Cited by 25
Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines
Akache, B., Stark, F. C., Agbayani, G., Renner, T. M., & McCluskie, M. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1892-9_9 · Cited by 32
Progress towards Adjuvant Development: Focus on Antiviral Therapy
Brai, A., Poggialini, F., Pasqualini, C., Trivisani, C. I., Vagaggini, C., & Dreassi, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119225 · Cited by 26
“Initially, the adjuvant properties of ABA were first ascribed to a “depot effect” [44].”
BackgroundInfluentialTaking off the brakes: T cell immunity in the liver
Kern, M., Popov, A., Kurts, C., Schultze, J. L., & Knolle, P. A. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.06.001 · Cited by 30
Type II NKT cells facilitate Alum-sensing and humoral immunity
Shah, H. B., Devera, T. S., Rampuria, P., Lang, G. A., & Lang, M. L. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0412177 · Cited by 28
SYK kinase signaling and the NLRP3 inflammasome in antifungal immunity
Poeck, H., & Ruland, J. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0631-4 · Cited by 27
“NLRP3 can be activated by multiple distinct exogenous and endogenous triggers which also include crystals (uric acid, silica, and asbestos [43–45]), bacteria (Staphylococcus aureus, Neiseria meningitides [46]), bacterial pore forming toxins [47], certain DNA (adenovirus) [48], RNA viruses (influenza virus) [49–51], va…”
BackgroundIntegrating Safety and Efficacy Evaluation Throughout Vaccine Research and Development
Curlin, G. T., Landry, S., Bernstein, J., Gorman, R. L., Mulach, B., Hackett, C. J., Foster, S. L., Miers, S. E., & Strickler-Dinglasan, P. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1722c · Cited by 25
“The NIAID recently awarded grants for a new program designed to characterizediversestatesof thehuman immune system (1) after infection, (2) before and after vaccination against an infectious disease, or (3) before and after treatment with an immune adjuvant that targets a known innate immune receptor(s).”
BackgroundChristo, S. N., Diener, K. R., Manavis, J., Grimbaldeston, M. A., Bachhuka, A., Vasilev, K. A., & Hayball, J. D. (2016) · Scientific Reports · doi:10.1038/srep20635 · Cited by 29
Varela-Martínez, E., Abendaño, N., Asín, J., Sistiaga-Poveda, M., Pérez, M. M., Reina, R., de Andrés, D., Luján, L., & Jugo, B. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02406 · Cited by 32
“Several reports have shown that secretion of inflammatory cytokines is induced by aluminum (47, 52– 54).”
BackgroundKim, S. T., Bittar, M. N., Kim, H. J., Neelapu, S. S., Zurita, A. J., Nurieva, R., & Suarez-Almazor, M. E. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0597-x · Cited by 25
The Protective Mechanism of Fluorofenidone in Renal Interstitial Inflammation and Fibrosis
Tang, Y., Zhang, F., Huang, L., Yuan, Q., Qin, J., Li, B., Wang, N., Xie, Y., Wang, L., Wang, W., et al. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000501 · Cited by 26
Amplifying the Immune Activity of Metal Ions through Metal–Phenolic Complexation
Wang, Z., Chen, J., Wang, T., Rose, R. D., Cortez‐Jugo, C., & Caruso, F. (2025) · ACS Nano · doi:10.1021/acsnano.5c01842 · Cited by 25
Detection of In Vivo Inflammasome Activation for Predicting Sepsis Mortality
Cui, J. Z., Oehrl, S., Ahmad, F., Brenner, T., Uhle, F., Nußhag, C., Rupp, C., Funck, F., Meisel, S., Weigand, M. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613745 · Cited by 25
Pan, J., Peng, J., Li, X., Wang, H., Rong, X., & Peng, Y. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03232-y · Cited by 35
Apilimod activates the NLRP3 inflammasome through lysosome-mediated mitochondrial damage
Hou, Y., He, H., Ma, M., & Zhou, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128700 · Cited by 28
“Endogenous insolubles (MSU crystals (12), cholesterol crystals (26, 27), amyloid-b aggregates (28) and exogenous particulates (silica and alum (11, 29)), could be phagocytosed by lysosomes and induce the NLRP3 inflammasome activation.”
BackgroundAlum, an aluminum-based adjuvant, induces Sjögren's syndrome-like disorder in mice.
Bagavant, H., Nandula, S. R., Kapłonek, P., Rybakowska, P., & Deshmukh, U. S. (2014) · PubMed · Cited by 24
McSorley, H. J., Blair, N. F., Robertson, E., & Maizels, R. M. (2015) · Experimental Parasitology · doi:10.1016/j.exppara.2015.02.009 · Cited by 27
“Of note, for functional TLR and IL-1R responses, both of the signaling molecules MyD88 and TRIF are required, although alum-induced allergic responses are intact in mice lacking either or both of these adapter proteins (Eisenbarth et al., 2008; Gavin et al., 2006; Piggott et al., 2005).”
BackgroundResultWilmar, A., Lonez, C., Vermeersch, M., Andrianne, M., Pérez-Morga, D. L., Ruysschaert, J., Vandenbranden, M., Léo, O., & Temmerman, S. T. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.10.071 · Cited by 24
“As expected from published data using TLR-4 ligands to prime ells [5,23], the sequential addition of diC14 amidine and alum nduced the in vitro production of IL-1 in human and murine PCs.”
BackgroundResultGeneral Strategies in Inflammasome Biology
Dubois, H., Wullaert, A., & Lamkanfi, M. (2016) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-41171-2_1 · Cited by 31
Verhoef, J. J. F., de Groot, A. M., van Moorsel, M. V. A., Ritsema, J. A. S., Beztsinna, N., Maas, C., & Schellekens, H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.025 · Cited by 27
“The inflammatory marker IL-1b is known to be produced by activated PBMC in response to nanoparticulates, such as colloidal aluminum oxide, zinc oxide and urate crystals [24,31,32].”
BackgroundWillis, W. L., Wang, L., Wada, T. T., Gardner, M., Abdouni, O., Hampton, J. M., Valiente, G. R., Young, N. A., Ardoin, S. P., Agarwal, S., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001078 · Cited by 25
“Remarkably the NLRP-3 agonist alum (20) induced the formation of HMGB1c in a concentration-dependentmanner in RAW264.”
BackgroundThe role of innate immunity in asthma development and protection: Lessons from the environment
Pivniouk, V. I., Gimenes-Júnior, J. A., Honeker, L. K., & Vercelli, D. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13508 · Cited by 24
Strategies for optimizing targeting and delivery of mucosal HIV vaccines
Ahlers, J. D., & Belyakov, I. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200939269 · Cited by 27
Zlatkovic, J., Tsouchnikas, G., Jarmer, J., Koessl, C., Stiasny, K., & Heinz, F. X. (2013) · Journal of Virology · doi:10.1128/jvi.01690-13 · Cited by 23
Nanomaterial journey in the gut: from intestinal mucosal interaction to systemic transport
Qiao, X., Bao, L., Liu, G., & Cui, X. (2024) · Nanoscale · doi:10.1039/d4nr02480j · Cited by 28
Adjuvants: friends in vaccine formulations against infectious diseases
Manríquez, G. G. G., & Tuero, I. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1934354 · Cited by 25
Sasaki, E., Asanuma, H., Momose, H., Furuhata, K., Mizukami, T., & Hamaguchi, I. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009890 · Cited by 24
“In other words, the present study shows that the cytokines mainly involved in the alum-associated mechanisms of allergy and pulmonary fibrosis might be different from those involved in the induction of IgA production [9, 10, 18].”
BackgroundSafety and Mechanism of Action of Licensed Vaccine Adjuvants
Rambe, D. S., Giudice, G. D., Rossi, S., & Sanicas, M. (2015) · International Current Pharmaceutical Journal · doi:10.3329/icpj.v4i8.24024 · Cited by 24
“As already described, NLRP3 has been implicated in Alum adjuvanticity (Eisenbarth et al., 2008).”
The expanding role of immunopharmacology: IUPHAR Review 16
Tiligada, E., Ishii, M., Riccardi, C., Spedding, M., Simon, H., Teixeira, M. M., Cuervo, M. L. C., Holgate, S. T., & Levi‐Schaffer, F. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13219 · Cited by 25
“Aluminium salts are the most commonly used adjuvants in clinical practice and activate another class of PRRs, namely the nucleotide-binding oligomerization domain (NOD)-like receptors (NLR), thus leading to the activation of APCs (Eisenbarth et al., 2008).”
BackgroundInfluentialPrecioso, A. R., Miraglia, J. L., Campos, L. M. A., Goulart, A. C., Timenetsky, M. D. C. S. T., Cardoso, M. R. A., Luna, E. J. D. A., Mondini, G., Guedes, J. D. S., & Raw, I. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.040 · Cited by 23
Deronic, A., Helmersson, S., Leanderson, T., & Ivars, F. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.12.008 · Cited by 28
“[26] Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA.”
BackgroundGetting Closer to the Dirty Little Secret
Pelka, K., & Latz, E. (2011) · Immunity · doi:10.1016/j.immuni.2011.04.003 · Cited by 23
“Whereas some studies found NLRP3, ASC, and caspase-1 to be required for aluminduced adjuvanticity (Eisenbarth et al., 2008), others failed to observe a role of NLRP3 (Franchi and Núñez, 2008).”
BackgroundDey, A., Burke, B., Sun, Y., Hartog, K., Heeney, J. L., Montefiori, D. C., Srivastava, I. K., & Barnett, S. W. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.02.027 · Cited by 26
“It is interesting to note that the in vivo mechanisms of action of alum, the oldest licensed adjuvant, and MF59, an adjuvant that has been licensed for 13 years in Novartis’ FLUAD® influenza vaccine, are just now being elucidated [10–15].”
Factors Influencing the Allergenicity and Adjuvanticity of Allergens
Deifl, S., & Bohle, B. (2011) · Immunotherapy · doi:10.2217/imt.11.69 · Cited by 28
Holers, V. M., Tomlinson, S., Kulik, L. N., Atkinson, C., Rohrer, B., Banda, N. K., & Thurman, J. M. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.05.007 · Cited by 23
“Although intracellular cytoplasmic pathways are commonly studied sensors of DAMPS, extracellular recognition by innate proteins also provides an important recognition mechanism [10, 47].”
BackgroundImmunomodulatory effects in workers exposed to naturally occurring asbestos fibers
Ledda, C., Costa, C., Matera, S., Puglisi, B., Costanzo, V., Bracci, M., Fenga, C., Rapisarda, V., & Loreto, C. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6384 · Cited by 23
Association of chitosan and aluminium as a new adjuvant strategy for improved vaccination
Lebre, F., Bento, D., Ribeiro, J. B., Colaço, M., Borchard, G., de Lima, M. C. P., & Borges, O. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.028 · Cited by 23
Itoh, Y., Ozaki, H., Ishigaki, H., Sakoda, Y., Nagata, T., Soda, K., Isoda, N., Miyake, T., Ishida, H., Okamoto, K., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.067 · Cited by 24
He, C., Liu, J., Li, J., Wu, H., Jiao, C., Ze, X., Xu, S., Zhu, Z., Guo, W., Xu, J., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00504 · Cited by 24
Xian, H., Watari, K., Ohira, M., Brito, J. S., He, P., Onyuru, J., Zúñiga, E. I., Hoffman, H. M., & Karin, M. (2025) · The Journal of Immunology · doi:10.1038/s41590-025-02179-7 · Cited by 29
Álvarez-Simón, D., Yahia, S. A., de Nadaï, P., Audousset, C., Chamaillard, M., Boneca, I. G., & Tsicopoulos, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.928886 · Cited by 23
Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy
Chen, W., Li, C., & Jiang, X. (2023) · Small Methods · doi:10.1002/smtd.202201404 · Cited by 23
Life-Threatening MOG Antibody-Associated Hemorrhagic ADEM With Elevated CSF IL-6
Virupakshaiah, A., Moseley, C. E., Elicegui, S., Gerwitz, L., Spencer, C. M., George, E., Shah, M. P., Cree, B., Waubant, E. L., & Zamvil, S. S. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200243 · Cited by 24
“28 Nevertheless, although the onset of neurologic symptoms 14 days after Tdap vaccination aligns with the WHO criteria for causality, 29”
BackgroundPyrin Domain (PYD)-containing Inflammasome in Innate Immunity
Hong, S., Park, S., & Yu, J. (2011) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2011.41.3.133 · Cited by 27
Alum Directly Modulates Murine B Lymphocytes to Produce IgG1 Isotype
Jin, B.-R., Kim, S., Lee, J.-M., Kang, S.-H., Han, H.-J., Jang, Y., Seo, G., & Kim, P.-H. (2013) · Immune Network · doi:10.4110/in.2013.13.1.10 · Cited by 22
“of inflammasome (6,7), 3) through lipid rafts (24).”
BackgroundThe p50 Subunit of NF-κB Orchestrates Dendritic Cell Lifespan and Activation of Adaptive Immunity
Larghi, P., Porta, C., Riboldi, E., Totaro, M. G., Carraro, L., Orabona, C., & Sica, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045279 · Cited by 22
“In this regard, the NLRP3 inflammasome complex is one of the molecular targets of adjuvants and it is required for adjuvanticity in dendritic cellbased vaccines [54,55], where adjuvant-mediated activation of both TLR and the inflammasome pathway [55,56] promotes IL18 and IL-1b-dependent antitumor immunity [54,57].”
Polymorphisms in the NLRP3 gene and risk of primary gouty arthritis
Meng, D.-M., Zhou, Y., Wang, L., REN, W., Cui, L., Han, L., Qu, Z., Li, C., & Zhao, J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1429 · Cited by 23
“Furthermore, NLRP3 inflammasomes induce the exposure of MHC-II on macrophage/antigen-presenting cell surfaces for a rapid non-self antigen presentation (34) and are important in the maturation and activation of dendritic cells (35,36).”
BackgroundKnockdown of NLRP5 arrests early embryogenesis in sows
Peng, H., Liu, F., Li, W., & Zhang, W. (2015) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2015.11.004 · Cited by 23
“The immunization-related genes are mainly nvolved in inflammation and immune responses (Boyden nd Dietrich, 2006; Eisenbarth et al., 2008, 2012; Gross t al., 2009; Satoh et al., 2014), while the reproduction- Please cite this article in press as: Peng, H., et al., Knockdown of N Sci. (2015),…”
BackgroundInfluenza Virus and SARS-CoV-2 Vaccines
Sandor, A., Sturdivant, M. S., & Ting, J. P. ‐. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001287 · Cited by 23
Schifanella, L., Barnett, S. W., Bissa, M., Galli, V., Doster, M. N., Vaccari, M., Tomaras, G. D., Shen, X., Phogat, S. K., Pal, R., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008121 · Cited by 26
“First, we demonstrated that in vitro IL-1β induction is reduced following stimulation of PBMCs with a low dose of AlumN.”
BackgroundInfluentialMechanisms and potential therapeutic targets in allergic inflammation: recent insights
von Gunten, S., Cortinas-Elizondo, F., Kollárik, M., Beißwenger, C., & Lepper, P. M. (2013) · Allergy · doi:10.1111/all.12312 · Cited by 23
“A critical role of the NLRP3 inflammasome was recently highlighted in experimental allergic asthma induced in the presence of aluminum hydroxide (alum) adjuvant (83).”
BackgroundNovel adjuvants for B cell immune responses
Loré, K., & Hedestam, G. B. K. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32832da082 · Cited by 23
Miyaki, C., Meros, M., Precioso, A. R., & Raw, I. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.04.127 · Cited by 22
Chen, H., Wang, B., Zhao, R., Gao, D., Guan, M., Zheng, L., Zhou, X., Chai, Z., Zhao, Y., & Feng, W. (2015) · Small · doi:10.1002/smll.201500136 · Cited by 21
Wang, L., Zhu, L.-R., Duan, C., Li, L., & Chen, G. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11035 · Cited by 25
“Once activated, NALP3 recruits the adapter ASC, which in turn recruits pro‐caspase‐1 (5,17).”
BackgroundRecent advances in self-adjuvanting glycoconjugate vaccines
Manabe, Y., Chang, T., & Fukase, K. (2020) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2020.11.006 · Cited by 22
Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms
Alarcon, N. O., Jaramillo, M., Mansour, H. M., & Sun, B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071448 · Cited by 21
Jin, N., Roark, C. L., Miyahara, N., Taube, C., Aydintug, M. K., Wands, J. M., Huang, Y., Hahn, Y., Gelfand, E. W., O’Brien, R. L., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803280 · Cited by 26
“The stimulatory properties of aluminum adjuvants, which are commonly used to induce Th2-type immunity to inert protein Ags and allergens, were shown to be based on the activation of an intracellular innate response system, known as the Nalp3 inflammasome, which then induces the release of specific cytokines capable of…”
BackgroundAdjuvants and lymphoma risk as part of the ASIA spectrum
Butnaru, D., & Shoenfeld, Y. (2015) · Immunologic Research · doi:10.1007/s12026-014-8622-0 · Cited by 21
Pfaar, O., Jung, K., Wolf, H., Decot, E., Kleine‐Tebbe, J., Klimek, L., & Wüstenberg, E. G. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02801.x · Cited by 22
Alum Activates the Bovine NLRP3 Inflammasome
Harte, C., Gorman, A. L., McCluskey, S., Carty, M., Bowie, A., Scott, C. J., Meade, K. G., & Lavelle, E. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01494 · Cited by 23
“In mice, loss of NLRP3 and caspase-1 abrogates alum-induced IL-1β secretion in vitro, while a role for caspase-8 has also been proposed (8, 17).”
Metadata
- Authors
- Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A.
- Affiliations
- Yale University (US)
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Flavell, Richard A.
- Venue
- Nature
- Published
- 2008-05-21
- Volume
- 453
- Issue
- 7198
- Pages
- 1122-1126
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4804622
- OpenAlex
- W1979991507
- Cited by
- 1,542
- References
- 45
- Citations by year
- 2026: 34 · 2025: 43 · 2024: 54 · 2023: 56 · 2022: 52 · 2021: 81 · 2020: 62 · 2019: 53 · 2018: 74 · 2017: 81 · 2016: 91 · 2015: 85 · 2014: 91 · 2013: 125 · 2012: 132
- FWCI
- 57.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Bill and Melinda Gates Foundation
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Institute of Allergy and Infectious Diseases (K08AI065517)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR007016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NLRP3 inflammasome, aluminum hydroxide adjuvant, vaccine adjuvants, innate immunity, macrophages, IL-1β, IL-18, caspase-1, ASC, humoral antibody response, adaptive immune response, Toll-like receptors, complete Freund's adjuvant
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Adjuvants, Immunologic, Alum Compounds, Animals, Antibodies, Carrier Proteins, Cytoskeletal Proteins, Enzyme Activation, T-Lymphocytes, Helper-Inducer, Immunity, Innate, Inflammation, Macrophages, Mice, Inbred C57BL, Potassium, Cell Death, Caspase 1, Interleukin-18, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.